首页> 美国卫生研究院文献>other >Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based real-world study
【2h】

Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based real-world study

机译:在西班牙经维生素K拮抗剂治疗的房颤女性和男性之间的INR控制质量和转换为非维生素K口服抗凝剂的质量。基于人口的真实世界研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundWorldwide, there is growing evidence that quality of international normalized ratio (INR) control in atrial fibrillation patients treated with Vitamin K Antagonists (VKA) is suboptimal. However, sex disparities in population-based real-world settings have been scarcely studied, as well as patterns of switching to second-line Non-VKA oral anticoagulants (NOAC). We aimed to assess the quality of INR control in atrial fibrillation patients treated with VKA in the region of Valencia, Spain, for the whole population and differencing by sex, and to identify factors associated with poor control. We also quantified switching to Non-VKA oral anticoagulants (NOAC) and we identified factors associated to switching.
机译:背景技术在世界范围内,越来越多的证据表明,接受维生素K拮抗剂(VKA)治疗的房颤患者的国际标准化比率(INR)控制质量不佳。然而,很少有人研究基于人口的真实世界中的性别差异,以及切换到二线非VKA口服抗凝剂(NOAC)的模式。我们旨在评估西班牙瓦伦西亚地区接受VKA治疗的房颤患者的INR控制质量,以总体人群和性别差异为基础,并确定与控制不佳相关的因素。我们还量化了使用非VKA口服抗凝剂(NOAC)的转换,并确定了与转换相关的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号